Medictur.ru
Medical laser therapy devices are used for selected clinical applications. The original article describes this as a relatively young field and presents laser exposure as having a proven beneficial “biostimulating” effect on the body. That broad description needs context: biological responses, clinical outcomes and safety depend on the condition, equipment and way it is used.
How laser therapy is proposed to affect the body
The source describes the devices and their effects as well studied and lists seven proposed responses:
- Cell renewal.
- Mobilisation of the body’s defences.
- Activation of self-regulation processes.
- Improved blood microcirculation in tissues.
- Reduced cholesterol levels.
- Stimulation of lymphatic flow.
- Improved immunity.
These retain the claims made by the original article; they are not established outcomes for every device or patient. In particular, a proposed cellular mechanism does not demonstrate a general cholesterol-lowering or immune-strengthening treatment.
The source also claims faster wound healing and greater resistance to viruses and allergic reactions, without side effects. Wound-healing applications require assessment of the particular wound and treatment; they do not establish protection against viral illness or allergy. Laser therapy cannot be described as universally free of adverse effects.
Some specific applications have supportive guidance. For example, NICE guidance on low-level laser therapy for oral mucositis considers evidence of efficacy adequate and permits the procedure with standard clinical governance, consent and audit arrangements. That condition-specific conclusion does not validate every systemic claim in the source.
Clinical treatment and home-use devices
The original discusses endocrine and cardiovascular diseases, age-related changes and a general strengthening effect, said to be equally pronounced in men and women. It also lists joint and spinal conditions. These descriptions cannot replace a diagnosis or establish equal benefit across conditions, sexes and devices. For osteoarthritis specifically, NICE recommends against offering laser therapy because there is insufficient evidence of benefit; this recommendation is not a verdict on all other uses.
The article describes applying a directed beam to painful points or tense areas, including tension associated with stress, and warming nerve endings and soft tissues. Low-level applications and heat-producing laser technologies should not be conflated. A sensation of warmth is not a measure of treatment effectiveness or a reason to select an exposure level.
The source calls the procedure effective and completely painless, while acknowledging that results are not immediate. It suggests that joint pain and swelling may decrease after the second session, with improved wellbeing and a general strengthening effect. That is an archived claim, not a predictable timetable or guarantee of painless treatment.
The original also describes exposure for 10–15 minutes at each painful point or problem area. This is a source example, not a treatment prescription. Exposure time alone does not define a safe or effective dose; parameters must follow the particular device’s instructions and the individual’s clinical assessment.
Laser treatment is presented as an additional physiotherapy method that can cure disease quickly while minimising medication. An adjunctive role does not establish a rapid cure or justify reducing prescribed medicines. Any change to medical treatment requires review by the treating clinician.
The source mentions magnetic–laser systems and devices combining electrical, light, magnetic, infrared and laser modalities, describing them as highly multifunctional. Combining technologies does not necessarily provide a “double effect” or superior clinical results. Each component’s intended use, evidence and precautions remain relevant.
It also describes relatively inexpensive home devices as no less effective than clinical equipment for pain and various diseases. Price and home availability do not establish equivalent performance or suitability. A clinical device should not be assumed suitable for unsupervised home use. For example, Enraf-Nonius describes the Endolaser 120 as intended for a healthcare provider in a clinical setting and requires appropriately trained operators. Its information lists precautions, contraindications and possible adverse effects, including restrictions on exposure to the eyes and regions of known or suspected malignancy.
Eye safety also matters. FDA guidance for low-level lasers used for aesthetic purposes identifies ocular injury and calls for device-specific instructions and appropriate eye-protection information. This guidance has an aesthetic-device scope; it does not certify the source’s proposed treatments for systemic diseases.
The source appropriately recommends consulting a clinician before home treatment, but its description of “minimal” contraindications cannot be applied to every device. Suitability, permitted users, supervision, eye protection and treatment parameters must follow the diagnosis and the exact equipment’s instructions. Consultation helps assess risks; it cannot guarantee effectiveness or eliminate every adverse effect.
Source: Zaplata: Medical Laser Therapy Devices — Treatment at Home and in the Clinic. Russian article on MEDICTUR.
